<DOC>
	<DOC>NCT00372801</DOC>
	<brief_summary>To demonstrate that new drugs work, many complex multidose studies are often required. The intent of this study is to use Ibuprofen as an example of a marketed pain relief drug to validate a simpler single dose model for future assessment of new pain drugs.</brief_summary>
	<brief_title>Effectiveness Of Single Doses Of Ibuprofen In Patients With Osteoarthritis Of The Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Inclusion criteria: Subjects diagnosed with primary Osteoarthritis of the knee. Have at least 3 months in symptom duration prior to screening visit. Regular user of a prescribed nonsteroidal antiinflammatory drug (NSAID) or selective cyclooxygenase II (COX2) inhibitor for management of knee pain. Pain walking on flat surface within specific interval prior to study start. Exclusion criteria: History of hypersensitivity to NSAIDS. Allergy to Ibuprofen. Use of assistive devices other than a cane or knee brace. History of specified diseases/illnesses. Abnormal blood tests prestudy.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Ibuprofen</keyword>
	<keyword>COX2</keyword>
	<keyword>VAS</keyword>
	<keyword>knee</keyword>
	<keyword>single dose</keyword>
</DOC>